[1] 国家药典委员会. 中华人民共和国药典(一部)[M]. 2020年版. 北京:中国医药科技出版社,2020.
[2] Son HL, Yen PTH. Preliminary phytochemical screening, acute oral toxicity and anticonvulsant activity of the berries of solanum nigrum linn[J]. Trop J Pharm Res, 2014, 13(6): 907-912. DOI: 10.4314/tjpr.v13i6.12.
[3] Wang HC, Wu DH, Chang YC, et al. Solanum nigrum Linn. water extract inhibits metastasis in mouse melanoma cells in vitro and in vivo[J]. J Agric Food Chem, 2010, 58(22): 11913-11923. DOI: 10.1021/jf1022065.
[4] Nirmal SA, Patel AP, Bhawar SB, et al. Antihistaminic and antiallergic actions of extracts of solanum nigrum berries: possible role in the treatment of asthma[J]. J Ethnopharmacol, 2012, 142(1): 91-97. DOI: 10.1016/j.jep.2012.04.019.
[5] Raju K, Anbuganapathi G, Gokulakrishnan V, et al. Effect of dried fruits of Solanum nigrum LINN against CCl4-induced hepatic damage in rats[J]. Biol Pharm Bull, 2003, 26(11):1618-1619. DOI: 10.1248/bpb.26.1618.
[6] Azarkish F, Hashemi K, Talebi A, et al. Effect of the administration of solanum nigrum fruit on prevention of diabetic nephropathy in streptozotocin-induced diabetic rats[J]. Pharmacognosy Res, 2017, 9(4): 325-332. DOI: 10.4103/pr.pr_47_17.
[7] 黄东彬,管静. 龙葵合剂对晚期肝癌患者生存质量及免疫功能的临床研究[J]. 时珍国医国药,2013,24(7):1676-1678. DOI:10.3969/j.issn.1008-0805.2013.07.058.
[8] 刘凤春,朱鸿,李晶,等. 龙葵合剂联合化疗对40例中晚期胃癌患者生存质量及免疫功能的临床研究[J]. 中国保健营养(下旬刊),2014,24(2):705-706. DOI:10.3969/j.issn.1004- 7484(x).2014.02.124.
[9] 黄东彬,管静. 龙葵合剂联合化疗对47例中晚期大肠癌患者生活质量和免疫功能的影响[J]. 亚太传统医药,2012,8(10):37-38. DOI:10.3969/j.issn.1673-2197.2012.10.018.
[10] 黄东彬,管静. 龙葵合剂治疗中晚期非小细胞肺癌54例临床观察[J]. 内蒙古中医药,2013,32(16):21-22. DOI:10.3969/j.issn.1006-0979.2013.16.023.
[11] 邬晓东,吴迪,徐立群等.龙葵合剂辅助鼻咽癌放射治疗35例临床观察[J].中药材,2013,36(8):1378-1380. DOI:10.13863/j.issn1001-4454.2013.08.011.
[12] 付春利,方子文,阮玲玲,等. 龙葵汤在乳腺癌化疗中的临床应用[J]. 亚太传统医药,2014,10(18):99-100.
[13] 管静,余泽洪,黄东彬,等. 龙葵合剂治疗晚期恶性肿瘤145例临床观察[J]. 中外健康文摘,2012(42):73-74. DOI:10.3969/j.issn.1672-5085.2012.42.059.
[14] Chen X, Dai X, Liu Y, et al. Solanum nigrum linn.: an insight into current research on traditional uses, phytochemistry, and pharmacology[J]. Front Pharmacol, 2022, 13: 918071. DOI: 10.3389/fphar.2022.918071.
[15] 梅全喜. 广东地产药材研究[M]. 广州: 广东科技出版社, 2011: 247.
[16] Guo SB, Tian Y, Jian LY. Optimization of ethanol extraction process of solanum nigrum linn. and structural confirmation of its compounds[J]. Asian Journal of Chemistry, 2014, 26(14): 4615-4618. DOI: 10.14233/ajchem.2014.16139A.
[17] 刘林凤,高宝益,高淑红. 高效液相色谱法测定龙葵中澳洲茄碱与澳洲茄边碱含量的研究[J]. 世界中西医结合杂志, 2013, 8(2): 144-146. DOI: 10.3969/j.issn.1673-6613. 2013.02.013.
[18] Nath LR, Gorantla JN, Thulasidasan AKT, et al. Author Correction: Evaluation of uttroside B, a saponin from solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma[J]. Sci Rep, 2020, 10(1): 20431. DOI: 10.1038/s41598-020-77440-0.
[19] Pei H, Yang J, Li W, et al. Solanum nigrum Linn.: advances in anti-cancer activity and mechanism in digestive system tumors[J]. Med Oncol, 2023, 40(11): 311. DOI: 10.1007/s12032-023-02167-7.
[20] 张帆,董鹏鹏,梅全喜. 不同产地的龙葵果中澳洲茄碱、澳洲茄边碱的含量测定比较研究[J]. 时珍国医国药,2017,28(12):2986-2987. DOI:10.3969/j.issn.1008-0805.2017. 12.061.
[21] 梅全喜,董鹏鹏,李红念,等. 鲜龙葵果治疗肿瘤的药理学基础与临床应用研究进展[J]. 时珍国医国药,2016,27(7):1713-1716. DOI:10.3969/j.issn.1008-0805.2016.07.064.
[22] 李学龙.中药配方颗粒和中药饮片的主要特点与效果[J].中医药管理杂志,2023,31(4):132-134. DOI: 10.16690/j.cnki.1007-9203.2023.04.098.
[23] 田凤,谢欣,王艳萍,等. 中药配方颗粒与饮片治疗高血压的效果及用药依从性比较[J]. 中国卫生标准管理,2021,12(13):124-126. DOI:10.3969/j.issn.1674-9316.2021. 13.040.
[24] 国家药品监督管理局. 关于征求«中药配方颗粒管理办法(征求意见稿)»意见的公告(2015年第283号)[EB/OL]. (2015-12-24) [2023-2-10]. http://www.sda.gov.cn/WS01/CL0778/140101.html.
[25] 国家药品监督管理局. 国家药监局关于发布«中药配方颗粒质量控制与标准制定技术要求»的通告(2021年第16号)[EB/OL]. (2021-1-26)[2023-2-10]. https://www.gov.cn/zhengce/zhengceku/2021-02/11/content_5586817.htm.
[26] 饶丽芬,李泳雪,郭隆钢. 中药配方颗粒质量标准薄层鉴别与液相指纹图谱/特征图谱研究现状及对照提取物应用可行性探讨[J]. 国际医药卫生导报,2022,28(21):2995-3003. DOI: 10.3760/cma.j.issn.1007-1245.2022.21.008.
[27] 杨洁,吕渭升,陈芳,等. 基于标准汤剂的紫苏梗配方颗粒质量标准研究[J]. 国际中医中药杂志,2022,44(10):1144-1149. DOI: 10.3760/cma.j.cn115398-20220308- 00091.
[28] 张文芳,林碧珊,梁浩明,等. 防己药材饮片及标准汤剂UPLC特征图谱研究[J]. 中国现代中药,2020,22(7):1113-1117. DOI: 10.13313/j.issn.1673-4890.201903140071.
[29] 邹纯才,鄢海燕. 我国中药色谱指纹图谱相似度评价方法30年( 1988-2017年) 研究进展与展望[J]. 中国中药杂志,2018,43(10):1969-1977. DOI: 10.19540/j.cnki.cjcmm. 20180115.0181.
[30] Zhang H, Tian F, Jiang P, Q et al. Solasonine suppresses the proliferation of acute monocytic leukemia through the activation of the AMPK/FOXO3A axis[J]. Front Oncol, 2021, 10: 614067. DOI: 10.3389/fonc.2020.614067.
[31] Chen Y, Tang Q, Xiao Q, et al. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells[J]. J Cell Mol Med, 2017, 21(2):222-233. DOI: 10.1111/jcmm.12958.
[32] Wang X, Zou S, Lan YL, et al. Solasonine inhibits glioma growth through anti-inflammatory pathways[J]. Am J Transl Res, 2017, 9(9):3977-3989.
[33] 刘秋琼,梅全喜,张锦超,等. 龙葵果保鲜技术对澳洲茄碱、澳洲茄边碱含量的影响[J]. 中药材,2015,38(4):727-729. DOI: 10.13863/j.issn1001-4454.2015.04.018.
|